C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
11/2006
11/22/2006	EP0783003B1 G-CSF TPO fusion proteins
11/22/2006	CN1867588A Product comprising a c4bp core protein and a monomeric antigen, and its use
11/22/2006	CN1865445A scFvC6.5-sTrail fusion gene and protein, and its preparation
11/22/2006	CN1865444A scFvC6.5-TNF-alpha fusion gene and protein, and its preparation
11/22/2006	CN1865286A Double function epidermal growth factor and its preparation method and uses
11/22/2006	CN1864746A Gene engineered poly-valence subunit vaccine of Hp AhpC and preparation method thereof
11/22/2006	CN1285613C Antineoplastic rat light chain single domain antibody - Cefuroxime Sodium reinforced fusion protein VL-LDP-AE
11/22/2006	CN1285609C Recombinant N protein antigen and purification method for transmissible gastroenteritis of swine
11/21/2006	US7138501 Antibodies that immunospecifically bind BLyS
11/21/2006	US7138497 Genetic engineering; crosslinking polypeptide on carrier
11/21/2006	US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/16/2006	US20060259993 Amidases, nucleic acids encoding them and methods for making and using them
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257856 Heterodimeric receptor libraries using phagemids
11/16/2006	US20060257418 Vaccine
11/16/2006	US20060257366 Chimeric glycoproteins and pseudotyped lentiviral vectors
11/16/2006	US20060257364 Materials and methods for inhibition of IgE production
11/15/2006	EP1721979A1 Compositions and methods for increasing bone mineralisation
11/15/2006	EP1720996A1 Fusion proteins containing recombinant cytotoxic rnases
11/15/2006	EP1720911A1 Fusion protein comprising tatdmt polypeptide
11/15/2006	EP1720899A2 Multimerised hiv fusion inhibitors
11/15/2006	EP1283869B1 Novel bee venom polypeptides and methods of use thereof
11/15/2006	CN1863820A Compounds comprising lpa
11/15/2006	CN1863815A Polypeptides having brain disposition activity and utilization of the same
11/15/2006	CN1861635A Human pancreas hyperglycemiacin relative peptide-2 analogue
11/14/2006	US7135612 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
11/14/2006	US7135320 Adaptor protein FRS2 and related products and methods
11/12/2006	CA2606334A1 Methods of using phhla2 to co-stimulate t-cells
11/09/2006	WO2006118350A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006	US20060253912 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/09/2006	US20060252695 Analysis and separation of platelet-derived growth factor proteins
11/09/2006	US20060252157 Larynx carcinoma-associated protein larcap-1
11/09/2006	US20060252130 Method for linking molecular substances
11/09/2006	US20060252034 Novel protein containing ring finger domaine r1p4
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	US20060251671 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/09/2006	US20060251643 Regulatory zinc finger proteins
11/09/2006	US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006	DE102005015832A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications
11/09/2006	CA2821389A1 Novel method for preventing or treating m tuberculosis infection
11/09/2006	CA2606450A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1718665A2 Hybrid polypeptides with selectable properties
11/08/2006	EP1237930B1 Chimeric amyloid beta peptides
11/08/2006	CN1283664C Erythropoietin conjugate
11/07/2006	US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006	US7132508 Mammalian chemokine reagents
11/07/2006	US7132259 nucleic acids encoding neurotoxin polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; for biosynthesis of botulinum neurotoxins in host cells
11/07/2006	US7132255 drug screening for compounds that enhance or suppress killer T cell activity by contacting a population of killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
11/07/2006	CA2128511C Monomeric and dimeric antibody-fragment fusion proteins
11/02/2006	WO2006074389A3 Four-helical bundle protein zsig99
11/02/2006	WO2003072715A3 Gasp1: a follistatin domain containing protein
11/02/2006	US20060248605 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2006	US20060247425 Glycosylated immunoglobulin and immunoadhesin comprising the same
11/02/2006	US20060246586 Chromosome-based platforms
11/02/2006	US20060246087 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration
11/02/2006	US20060246067 Immunomodulatory constructs and their uses
11/02/2006	US20060246046 Modified tridegins, production and use thereof as transglutaminase inihibitors
11/02/2006	EP1716174A2 Leucine rich repeat containing protein
11/02/2006	EP1644410A4 Sushi peptide multimer
11/02/2006	EP1105157B1 Protein delivery system using human papillomavirus virus-like particles
11/02/2006	EP1009834B1 Regulation of protein secretion
11/01/2006	CN1854299A Production of recombinant insulinum primary C peptide
11/01/2006	CN1854298A Chimeric gene with delta 6 fatty acid dehydrogenase function and its use
11/01/2006	CN1853730A Modified cytokines for use in cancer therapy
10/2006
10/31/2006	US7129060 Export systems for recombinant proteins
10/31/2006	CA2332183C Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use
10/31/2006	CA2129733C Mammalian expression systems for hcv proteins
10/26/2006	US20060240567 Method of immobilizing a protein to a zeolite
10/26/2006	US20060240528 Polyketides and their synthesis
10/26/2006	US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity
10/26/2006	US20060240519 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
10/26/2006	US20060240517 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240516 Interacting polypeptide comprising a heptapeptide pattern and a cell penetration domain
10/26/2006	US20060240414 Genetically engineered glutaminase and its use in antiviral and anticancer therapy
10/26/2006	US20060240004 Methods for treating tweak-related conditions
10/26/2006	US20060240003 Humanised antibodies to the epidermal growth factor receptor
10/26/2006	CA2604515A1 Toll-like receptor 14 (tlr14 ) and use thereof
10/25/2006	EP1715043A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/25/2006	EP1715040A2 Zinc finger binding domains for GNN
10/25/2006	EP1714982A2 Methods for purifying highly anionic proteins
10/25/2006	EP1714980A1 Human receptor proteins, related reagents and methods
10/25/2006	EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/25/2006	EP1507869A4 Improved receptor detection
10/25/2006	EP1254181B1 Diagnostic assay for type 2 heparin-induced thrombocytopenia
10/25/2006	CN1852736A Immunoglobulin chimeric monomer-dimer hybrids
10/25/2006	CN1281621C Method of diagnosing and treating heritage spasm paraplegia using NIPAl gene mutation hot point
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125703 Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
10/24/2006	US7125699 for treating solid tumours, macular degeneration, corneal rejection, psoriasis, rheumatoid arthritis and chronic ulceration, and diseases involving vascular insufficiency, including stroke and following heart attack
10/24/2006	US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125554 Engineered superantigen for human therapy
10/19/2006	WO2006109303A2 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
10/19/2006	WO2006108226A1 Vaccine delivery system
10/19/2006	WO2006080837A3 Means and methods for breaking noncovalent binding interactions between molecules
10/19/2006	US20060236411 Antagonists il-15
10/19/2006	US20060235201 Enduring T cell response
10/19/2006	US20060234917 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation

1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 295